Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H31N3O3 |
| Molecular Weight | 385.4998 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)[C@@H](NC(=O)C1=NN(CC2CCCCC2)C3=C1C=CC=C3)C(C)(C)C
InChI
InChIKey=DGQMLBSSRFFINY-LJQANCHMSA-N
InChI=1S/C22H31N3O3/c1-22(2,3)19(21(27)28-4)23-20(26)18-16-12-8-9-13-17(16)25(24-18)14-15-10-6-5-7-11-15/h8-9,12-13,15,19H,5-7,10-11,14H2,1-4H3,(H,23,26)/t19-/m1/s1
| Molecular Formula | C22H31N3O3 |
| Molecular Weight | 385.4998 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:50:30 GMT 2023
by
admin
on
Sat Dec 16 11:50:30 GMT 2023
|
| Record UNII |
Z6EXBVG316
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-MDMB-CHMINACA
Created by
admin on Sat Dec 16 11:50:30 GMT 2023 , Edited by admin on Sat Dec 16 11:50:30 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
MDMB-CHMINACA
Created by
admin on Sat Dec 16 11:50:30 GMT 2023 , Edited by admin on Sat Dec 16 11:50:30 GMT 2023
|
PRIMARY | DOSE: 1-5 mg smoked MDMB-CHMICA (plant material) | ||
|
MDMB-CHMINACA
Created by
admin on Sat Dec 16 11:50:30 GMT 2023 , Edited by admin on Sat Dec 16 11:50:30 GMT 2023
|
PRIMARY | MDMB-CHMINACA (also known as MDMB(N)-CHM) is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. It is closely related to MDMB-FUBINACA, which caused at least 1000 hospitalizations and 40 deaths in Russia as consequence of intoxication. MDMB-CHMINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015. MDMB-CHMINACA is illegal in Switzerland as of December 2015. | ||
|
DTXSID00101003
Created by
admin on Sat Dec 16 11:50:30 GMT 2023 , Edited by admin on Sat Dec 16 11:50:30 GMT 2023
|
PRIMARY | |||
|
1185888-32-7
Created by
admin on Sat Dec 16 11:50:30 GMT 2023 , Edited by admin on Sat Dec 16 11:50:30 GMT 2023
|
PRIMARY | |||
|
121491808
Created by
admin on Sat Dec 16 11:50:30 GMT 2023 , Edited by admin on Sat Dec 16 11:50:30 GMT 2023
|
PRIMARY | |||
|
Z6EXBVG316
Created by
admin on Sat Dec 16 11:50:30 GMT 2023 , Edited by admin on Sat Dec 16 11:50:30 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
Ki
|
||
|
TARGET -> AGONIST |
Ki
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
